Will Canopy Growth Corp (TSX:WEED) Hit $1 Billion in Sales Next Year?

Some are predicting that Canopy Growth Corp (TSX:WEED)(NYSE:CGC) will hit $1 billion in sales for 2019

| More on:
edit Business accounting concept, Business man using calculator with computer laptop, budget and loan paper in office.

Image source: Getty Images

Remember the Canopy Growth Corp (TSX:WEED)(NYSE:CGC)/Constellation Brands (NYSE:STZ) acquisition?

Last year, it was one of the biggest stories in the Canadian markets. After months of legalization hype, Constellation announced in August that it would be acquiring a huge $5 billion stake in Canopy, bringing its total ownership to 35%. The acquisition began a massive rally in weed stocks that raised not only Canopy, but also most of its competitors.

Since last fall, the Constellation deal has seen few new developments. But the company’s CEO recently spoke out in a rare public comment that may reveal why Constellation was willing to pay so much in the 2018 deal.

Constellation CEO says Canopy headed to $1 billion in annual revenue

In a recent conference call, Constellation Brands CEO Bill Newlands claimed that Canopy Growth would hit $1 billion in revenue by 2020. This was not the first time that Newlands made this claim. However, it was the first time he was able to back it up with clear data. Using Canopy’s $83 million in Q3 revenue and 282% net revenue growth rate, he concluded that a “run rate” of $1 billion was within striking distance.

Why $1 billion is such a crucial benchmark

You see, $1 billion in revenue is a crucial milestone for Constellation Brands for one simple reason: its stake in Canopy is massive. Not only did it invest $5 billion in Canopy stock last year, but it took a smaller stake a few months prior to that. This is a company with a huge chunk of coin riding on Canada’s largest weed stock. A valuation of $5 billion implies that Canopy will be worth that much from its discounted future cash flows–notwithstanding the possibility of Constellation simply dumping its Canopy shares at a high price.

For Canopy to be worth that much over, say, a 50-year period, it needs to generate $100 million a year in net income for 50 years. Given the typical profit margins in the cannabis space, the company would therefore have to start doing well over a billion in sales to be worth what Constellation paid for it.

Canopy’s revenue growth

It’s definitely within the realm of possibility that Canopy could hit $1 billion in revenue this year or the next. Judging by last quarter’s sales, the company could earn up to $332 million this year. If last quarter’s net revenue growth rate stays steady into next year at 280%, then that $332 million could rise to $929 million next year. That’s just a hair short of a billion.

Also, if Canopy sees accelerating revenue growth this year, it’s not impossible that the company could even hit the $1 billion mark before 2019 is out. However, it would require significant acceleration, as Canopy’s quarter by quarter revenue growth in 2018 was not amazing. In Q2 (which corresponds to Q3 of the 2018 calendar year), for example, revenue was actually down from Q1, at $23 million vs $25 million.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »